{"id":15063,"date":"2025-10-12T13:06:28","date_gmt":"2025-10-12T12:06:28","guid":{"rendered":"https:\/\/resemedicin.se\/reseradet\/?p=15063"},"modified":"2025-10-14T06:23:37","modified_gmt":"2025-10-14T05:23:37","slug":"2025-10-12-nytt-konjugerat-pneumokockvaccin-capvaxive-for-vuxna-lanserat-i-sverige","status":"publish","type":"post","link":"https:\/\/resemedicin.se\/reseradet\/epinytt\/2025-10-12-nytt-konjugerat-pneumokockvaccin-capvaxive-for-vuxna-lanserat-i-sverige\/","title":{"rendered":"2025-10-12 Nytt konjugerat pneumokockvaccin: Capvaxive\u00ae f\u00f6r vuxna lanserat i Sverige"},"content":{"rendered":"\n<p>Ett nytt 21-valent konjugerat pneumokockvaccin (PCV21) f\u00f6r vuxna,&nbsp;<a href=\"https:\/\/www.fass.se\/LIF\/product?userType=0&amp;nplId=20240314000035\" target=\"_blank\" rel=\"noreferrer noopener\">Capvaxive\u00ae<\/a>, finns nu p\u00e5 den svenska marknaden. Vaccinet \u00e4r&nbsp;<a href=\"https:\/\/www.ema.europa.eu\/en\/documents\/rmp\/capvaxive-epar-risk-management-plan_en.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">EU-godk\u00e4nt<\/a> sedan 24 mars 2025&nbsp;f\u00f6r&nbsp;f\u00f6rebyggande av invasiv pneumokocksjukdom (IPD) och pneumoni&nbsp;hos personer&nbsp;\u226518 \u00e5r&nbsp;och ges som&nbsp;en eng\u00e5ngsdos intramuskul\u00e4rt.<\/p>\n\n\n\n<p>Capvaxive\u00ae inneh\u00e5ller&nbsp;21 serotyper&nbsp;(3, 6A, 7F, 8, 9N, 10A, 11A, 12F, 15A,&nbsp;15B, 16F, 17F, 19A, 20A, 22F,&nbsp;23A, 23B, 24F, 31, 33F, 35B) och \u00e4r s\u00e4rskilt utformat f\u00f6r att t\u00e4cka de serotyper som orsakar majoriteten av vuxen IPD i Europa. I j\u00e4mf\u00f6rande immunogenitetsstudier gav PCV21 likv\u00e4rdigt eller h\u00f6gre antikroppssvar \u00e4n PCV20\/PPV23 f\u00f6r flertalet serotyper. Sju av de ing\u00e5ende serotyper i PCV21 t\u00e4cks inte av n\u00e5got annat pneumokockvaccin&nbsp;(15A, 16F, 23A, 23B, 24F, 31 och 35B). I grafen nedan ses en j\u00e4mf\u00f6relse avseende serotyper med \u00f6vriga pneumokockvaccin; <a href=\"https:\/\/resemedicin.se\/reseradet\/vaccination\/vaxneuvance\/\">Vaxneuvance\u00ae<\/a> (PCV15), <a href=\"https:\/\/resemedicin.se\/reseradet\/vaccination\/prevenar-20\/\">Prevenar 20\u00ae<\/a> (PCV20) och polysackaridvaccinet <a href=\"https:\/\/resemedicin.se\/reseradet\/vaccination\/pneumovax\/\">Pneumovax\u00ae<\/a>&nbsp;(PPV23).<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img data-recalc-dims=\"1\" loading=\"lazy\" decoding=\"async\" width=\"840\" height=\"116\" src=\"https:\/\/i0.wp.com\/resemedicin.se\/reseradet\/wp-content\/uploads\/2025\/10\/image-6.png?resize=840%2C116&#038;ssl=1\" alt=\"\" class=\"wp-image-15069\" srcset=\"https:\/\/i0.wp.com\/resemedicin.se\/reseradet\/wp-content\/uploads\/2025\/10\/image-6.png?resize=1024%2C141&amp;ssl=1 1024w, https:\/\/i0.wp.com\/resemedicin.se\/reseradet\/wp-content\/uploads\/2025\/10\/image-6.png?resize=300%2C41&amp;ssl=1 300w, https:\/\/i0.wp.com\/resemedicin.se\/reseradet\/wp-content\/uploads\/2025\/10\/image-6.png?resize=768%2C106&amp;ssl=1 768w, https:\/\/i0.wp.com\/resemedicin.se\/reseradet\/wp-content\/uploads\/2025\/10\/image-6.png?resize=1536%2C212&amp;ssl=1 1536w, https:\/\/i0.wp.com\/resemedicin.se\/reseradet\/wp-content\/uploads\/2025\/10\/image-6.png?resize=2048%2C282&amp;ssl=1 2048w, https:\/\/i0.wp.com\/resemedicin.se\/reseradet\/wp-content\/uploads\/2025\/10\/image-6.png?resize=1200%2C165&amp;ssl=1 1200w, https:\/\/i0.wp.com\/resemedicin.se\/reseradet\/wp-content\/uploads\/2025\/10\/image-6.png?w=1680&amp;ssl=1 1680w\" sizes=\"auto, (max-width: 709px) 85vw, (max-width: 909px) 67vw, (max-width: 1362px) 62vw, 840px\" \/><\/figure>\n\n\n\n<h5 class=\"wp-block-heading\"><strong>Reser\u00e5dets kommentar<\/strong><\/h5>\n\n\n\n<p>F\u00f6r vuxna med mycket h\u00f6g risk f\u00f6r IPD som beh\u00f6ver maximera skyddet mot pneumokocker ger&nbsp;Capvaxive\u00ae (PCV21)&nbsp;i&nbsp;kombination med Pneumovax\u00ae (PPV23)&nbsp;den&nbsp;st\u00f6rsta m\u00f6jliga serotypst\u00e4ckningen (31 serotyper). Capvaxive\u00ae tillf\u00f6r flera vuxenrelevanta serotyper som saknas i andra konjugatvaccin, medan Pneumovax\u00ae bidrar med ytterligare serotyper (1, 2, 4, 5, 6B, 9V, 14, 18C, 19F, och 23F) som inte ing\u00e5r i PCV21. Som alltid ska konjugatvaccin ges f\u00f6re polysackaridvaccin med minst 2 m\u00e5naders intervall n\u00e4r sekventiell strategi \u00e4r aktuell.<\/p>\n\n\n\n<p style=\"font-size:12px\"><em><strong>EpiNytt\u00a0<\/strong><\/em>\u00e4r Reser\u00e5dets kostnadsfria omv\u00e4rldsbevakning med aktuell information om\u00a0utbrott och nyheter p\u00e5 vaccin- och resefronten. Se\u00a0<a href=\"https:\/\/resemedicin.se\/reseradet\/epinytt\/\">hela listan med nyheter i fulltext<\/a>. Dela g\u00e4rna l\u00e4nken med intresserade kolleger, vilka ocks\u00e5 sj\u00e4lva kan\u00a0<a href=\"https:\/\/resemedicin.se\/reseradet\/prenumerera-kostnadsfritt-pa-epinytt\/\">prenumerera p\u00e5 nyhetsbrevet<\/a>\u00a0utan kostnad.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Ett nytt 21-valent konjugerat pneumokockvaccin (PCV21) f\u00f6r vuxna,&nbsp;Capvaxive\u00ae, finns nu p\u00e5 den svenska marknaden. Vaccinet \u00e4r&nbsp;EU-godk\u00e4nt sedan 24 mars 2025&nbsp;f\u00f6r&nbsp;f\u00f6rebyggande av invasiv pneumokocksjukdom (IPD) och pneumoni&nbsp;hos personer&nbsp;\u226518 \u00e5r&nbsp;och ges som&nbsp;en eng\u00e5ngsdos intramuskul\u00e4rt. Capvaxive\u00ae inneh\u00e5ller&nbsp;21 serotyper&nbsp;(3, 6A, 7F, 8, 9N, 10A, 11A, 12F, 15A,&nbsp;15B, 16F, 17F, 19A, 20A, 22F,&nbsp;23A, 23B, 24F, 31, 33F, 35B) och \u00e4r &hellip; <a href=\"https:\/\/resemedicin.se\/reseradet\/epinytt\/2025-10-12-nytt-konjugerat-pneumokockvaccin-capvaxive-for-vuxna-lanserat-i-sverige\/\" class=\"more-link\">Forts\u00e4tt l\u00e4sa<span class=\"screen-reader-text\"> \u201d2025-10-12 Nytt konjugerat pneumokockvaccin: Capvaxive\u00ae f\u00f6r vuxna lanserat i Sverige\u201d<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"aside","meta":{"_lmt_disableupdate":"no","_lmt_disable":"","_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[2],"tags":[],"class_list":["post-15063","post","type-post","status-publish","format-aside","hentry","category-epinytt","post_format-post-format-aside"],"modified_by":"Reser\u00e5det","jetpack_featured_media_url":"","jetpack-related-posts":[{"id":15880,"url":"https:\/\/resemedicin.se\/reseradet\/epinytt\/2026-01-25-uppdaterade-rekommendationer-om-pneumokockvaccination-till-riskgrupper\/","url_meta":{"origin":15063,"position":0},"title":"2026-01-25 Uppdaterade rekommendationer om pneumokockvaccination till riskgrupper","author":"Reser\u00e5det","date":"2026-01-25","format":"aside","excerpt":"Folkh\u00e4lsomyndigheten har nyligen\u00a0uppdaterat sina rekommendationer om pneumokockvaccination till riskgrupper. Den viktigaste nyheten i den uppdaterade versionen \u00e4r att\u00a0alla riskgrupper nu rekommenderas vaccination med konjugerat pneumokockvaccin. F\u00f6r personer i riskgrupper rekommenderas konjugatvaccin som inneh\u00e5ller\u00a0minst 20 serotyper. F\u00f6r vuxna finns i dag tv\u00e5 s\u00e5dana vacciner godk\u00e4nda: ett 20-valent (PCV20, Prevenar 20\u00ae), och\u2026","rel":"","context":"I \u201dEpiNytt\u201d","block_context":{"text":"EpiNytt","link":"https:\/\/resemedicin.se\/reseradet\/kategori\/epinytt\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/resemedicin.se\/reseradet\/wp-content\/uploads\/2026\/01\/image-5.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/resemedicin.se\/reseradet\/wp-content\/uploads\/2026\/01\/image-5.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/resemedicin.se\/reseradet\/wp-content\/uploads\/2026\/01\/image-5.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/resemedicin.se\/reseradet\/wp-content\/uploads\/2026\/01\/image-5.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/resemedicin.se\/reseradet\/wp-content\/uploads\/2026\/01\/image-5.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/resemedicin.se\/reseradet\/wp-content\/uploads\/2026\/01\/image-5.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":12581,"url":"https:\/\/resemedicin.se\/reseradet\/nyheter\/2025-01-10-nya-amerikanska-rekommendationer-rorande-pneumokockvaccination-till-personer-50-ar\/","url_meta":{"origin":15063,"position":1},"title":"2025-01-10 Nya amerikanska rekommendationer r\u00f6rande pneumokockvaccination till personer >50 \u00e5r","author":"Reser\u00e5det","date":"2025-01-10","format":"aside","excerpt":"Amerikanska Advisory Committee on Immunization Practices (ACIP) har uppdaterat sina rekommendationer r\u00f6rande pneumokockvaccination till personer >50 \u00e5r. Baserat p\u00e5 tillg\u00e4ngliga h\u00e4lsoekonomiska och epidemiologiska data rekommenderas nu allm\u00e4n vaccination mot pneumokocker \u00e4ven till icke-immunsupprimerade personer \u00e4ldre \u00e4n 50 \u00e5r, enligt f\u00f6ljande*: Ingen tidigare eller endast PCV7, oavsett n\u00e4r: En eng\u00e5ngsdos av\u2026","rel":"","context":"I \u201dNyheter\u201d","block_context":{"text":"Nyheter","link":"https:\/\/resemedicin.se\/reseradet\/kategori\/nyheter\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":16559,"url":"https:\/\/resemedicin.se\/reseradet\/epinytt\/2025-03-27-lovande-fas-3-data-for-nytt-borreliavaccin-vla15\/","url_meta":{"origin":15063,"position":2},"title":"2025-03-27 Lovande fas 3-data f\u00f6r nytt borreliavaccin (VLA15)","author":"Reser\u00e5det","date":"2026-03-27","format":"aside","excerpt":"VLA15, ett rekombinant multivalent vaccin mot borrelia utvecklat av Valneva och Pfizer, har i en f\u00f6rsta av tv\u00e5 pivotala fas 3-studier visat god skyddseffekt och gynnsam s\u00e4kerhetsprofil. Studien omfattar flera tusen deltagare i endemiska omr\u00e5den i Nordamerika och Europa. Vaccinet \u00e4r riktat mot ytproteinet OspA fr\u00e5n sex olika\u00a0Borrelia-serotyper, vilket speglar\u2026","rel":"","context":"I \u201dEpiNytt\u201d","block_context":{"text":"EpiNytt","link":"https:\/\/resemedicin.se\/reseradet\/kategori\/epinytt\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":14575,"url":"https:\/\/resemedicin.se\/reseradet\/epinytt\/2025-07-20-okning-av-dengue-i-vastra-stillahavsregionen\/","url_meta":{"origin":15063,"position":3},"title":"2025-07-20 \u00d6kning av dengue i v\u00e4stra Stillahavsregionen","author":"Reser\u00e5det","date":"2025-07-20","format":"aside","excerpt":"Flera \u00f6nationer i v\u00e4stra Stilla Havet, d\u00e4ribland Amerikanska Samoa, Australien, Cook\u00f6arna, Franska Polynesien, Nya Zeeland, Samoa, Tonga och Tuvalu har de senaste m\u00e5naderna rapporterat utbrott av denguefeber. I b\u00f6rjan av juli f\u00f6rklarade Amerikanska Samoas h\u00e4lsodepartement det p\u00e5g\u00e5ende dengueutbrottet i landet som en folkh\u00e4lsokris, med DENV-1 och DENV-2 som dominerande serotyper.\u2026","rel":"","context":"I \u201dEpiNytt\u201d","block_context":{"text":"EpiNytt","link":"https:\/\/resemedicin.se\/reseradet\/kategori\/epinytt\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":14970,"url":"https:\/\/resemedicin.se\/reseradet\/epinytt\/2025-09-22-denguefeber-i-bangladesh-fortsatt-allvarligt-lage\/","url_meta":{"origin":15063,"position":4},"title":"2025-09-22 Denguefeber i Bangladesh \u2013 fortsatt allvarligt l\u00e4ge","author":"Reser\u00e5det","date":"2025-09-22","format":"aside","excerpt":"Vi rapporterade tidigare i juli om ett stort dengueutbrottet i Bangladesh. Situationen har nu f\u00f6rv\u00e4rrats ytterligare. Enligt landets h\u00e4lsomyndigheter rapporterades 12 d\u00f6dsfall under ett enda dygn den 21 september \u2013 den h\u00f6gsta dagsnoteringen hittills denna s\u00e4song. Totalt har 179 personer avlidit sedan \u00e5rets b\u00f6rjan och \u00f6ver 48 800 fall har\u2026","rel":"","context":"I \u201dEpiNytt\u201d","block_context":{"text":"EpiNytt","link":"https:\/\/resemedicin.se\/reseradet\/kategori\/epinytt\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":15159,"url":"https:\/\/resemedicin.se\/reseradet\/epinytt\/2025-10-31dengue-i-amerika-fortsatt-hog-aktivitet-trots-nedgang-fran-rekordaret-2024\/","url_meta":{"origin":15063,"position":5},"title":"2025-10-31 Dengue i Amerika \u2013 fortsatt h\u00f6g aktivitet trots nedg\u00e5ng fr\u00e5n rekord\u00e5ret 2024","author":"Reser\u00e5det","date":"2025-10-31","format":"aside","excerpt":"Enligt Pan American Health Organization (PAHO) har regionen\u00a0Amerika rapporterat cirka 3 870 000 fall av denguefeber t.o.m. vecka 40 2025, motsvarande en incidens p\u00e5 omkring 380 fall per 100 000 inv\u00e5nare. Trots att antalet fall \u00e4r betydligt l\u00e4gre \u00e4n rekord\u00e5ret 2024, d\u00e5 \u00f6ver 13 miljoner fall rapporterades, ligger \u00e5rets niv\u00e5\u2026","rel":"","context":"I \u201dEpiNytt\u201d","block_context":{"text":"EpiNytt","link":"https:\/\/resemedicin.se\/reseradet\/kategori\/epinytt\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/resemedicin.se\/reseradet\/wp-json\/wp\/v2\/posts\/15063","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/resemedicin.se\/reseradet\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/resemedicin.se\/reseradet\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/resemedicin.se\/reseradet\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/resemedicin.se\/reseradet\/wp-json\/wp\/v2\/comments?post=15063"}],"version-history":[{"count":2,"href":"https:\/\/resemedicin.se\/reseradet\/wp-json\/wp\/v2\/posts\/15063\/revisions"}],"predecessor-version":[{"id":15071,"href":"https:\/\/resemedicin.se\/reseradet\/wp-json\/wp\/v2\/posts\/15063\/revisions\/15071"}],"wp:attachment":[{"href":"https:\/\/resemedicin.se\/reseradet\/wp-json\/wp\/v2\/media?parent=15063"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/resemedicin.se\/reseradet\/wp-json\/wp\/v2\/categories?post=15063"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/resemedicin.se\/reseradet\/wp-json\/wp\/v2\/tags?post=15063"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}